nodes	percent_of_prediction	percent_of_DWPC	metapath
Altretamine—Peripheral sensory neuropathy—Sorafenib—thyroid cancer	0.132	0.132	CcSEcCtD
Altretamine—Neoplasm—Vandetanib—thyroid cancer	0.0506	0.0506	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Epirubicin—thyroid cancer	0.0488	0.0488	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Doxorubicin—thyroid cancer	0.0452	0.0452	CcSEcCtD
Altretamine—Neoplasm malignant—Sorafenib—thyroid cancer	0.0442	0.0442	CcSEcCtD
Altretamine—Neurotoxicity—Epirubicin—thyroid cancer	0.036	0.036	CcSEcCtD
Altretamine—Neoplasm—Sorafenib—thyroid cancer	0.0341	0.0341	CcSEcCtD
Altretamine—Neurotoxicity—Doxorubicin—thyroid cancer	0.0333	0.0333	CcSEcCtD
Altretamine—Myelosuppression—Epirubicin—thyroid cancer	0.0297	0.0297	CcSEcCtD
Altretamine—Myelosuppression—Doxorubicin—thyroid cancer	0.0275	0.0275	CcSEcCtD
Altretamine—Convulsion—Vandetanib—thyroid cancer	0.0212	0.0212	CcSEcCtD
Altretamine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.0207	0.0207	CcSEcCtD
Altretamine—Thrombocytopenia—Vandetanib—thyroid cancer	0.0195	0.0195	CcSEcCtD
Altretamine—Decreased appetite—Vandetanib—thyroid cancer	0.0173	0.0173	CcSEcCtD
Altretamine—Fatigue—Vandetanib—thyroid cancer	0.0172	0.0172	CcSEcCtD
Altretamine—Neoplasm malignant—Epirubicin—thyroid cancer	0.0163	0.0163	CcSEcCtD
Altretamine—Anaemia—Sorafenib—thyroid cancer	0.0152	0.0152	CcSEcCtD
Altretamine—Neoplasm malignant—Doxorubicin—thyroid cancer	0.0151	0.0151	CcSEcCtD
Altretamine—Leukopenia—Sorafenib—thyroid cancer	0.0148	0.0148	CcSEcCtD
Altretamine—Asthenia—Vandetanib—thyroid cancer	0.0143	0.0143	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.0139	0.0139	CcSEcCtD
Altretamine—Dizziness—Vandetanib—thyroid cancer	0.0132	0.0132	CcSEcCtD
Altretamine—Thrombocytopenia—Sorafenib—thyroid cancer	0.0132	0.0132	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.0129	0.0129	CcSEcCtD
Altretamine—Anorexia—Sorafenib—thyroid cancer	0.0128	0.0128	CcSEcCtD
Altretamine—Vomiting—Vandetanib—thyroid cancer	0.0127	0.0127	CcSEcCtD
Altretamine—Neoplasm—Epirubicin—thyroid cancer	0.0126	0.0126	CcSEcCtD
Altretamine—Nausea—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Altretamine—Decreased appetite—Sorafenib—thyroid cancer	0.0117	0.0117	CcSEcCtD
Altretamine—Neoplasm—Doxorubicin—thyroid cancer	0.0117	0.0117	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.0116	0.0116	CcSEcCtD
Altretamine—Fatigue—Sorafenib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.0108	0.0108	CcSEcCtD
Altretamine—Asthenia—Sorafenib—thyroid cancer	0.00966	0.00966	CcSEcCtD
Altretamine—Ataxia—Epirubicin—thyroid cancer	0.00952	0.00952	CcSEcCtD
Altretamine—Dizziness—Sorafenib—thyroid cancer	0.0089	0.0089	CcSEcCtD
Altretamine—Ataxia—Doxorubicin—thyroid cancer	0.00881	0.00881	CcSEcCtD
Altretamine—Vomiting—Sorafenib—thyroid cancer	0.00856	0.00856	CcSEcCtD
Altretamine—Pancytopenia—Epirubicin—thyroid cancer	0.00831	0.00831	CcSEcCtD
Altretamine—Nausea—Sorafenib—thyroid cancer	0.008	0.008	CcSEcCtD
Altretamine—Pancytopenia—Doxorubicin—thyroid cancer	0.00769	0.00769	CcSEcCtD
Altretamine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00765	0.00765	CcSEcCtD
Altretamine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00708	0.00708	CcSEcCtD
Altretamine—Anaemia—Epirubicin—thyroid cancer	0.00563	0.00563	CcSEcCtD
Altretamine—Vertigo—Epirubicin—thyroid cancer	0.00548	0.00548	CcSEcCtD
Altretamine—Leukopenia—Epirubicin—thyroid cancer	0.00546	0.00546	CcSEcCtD
Altretamine—Convulsion—Epirubicin—thyroid cancer	0.00528	0.00528	CcSEcCtD
Altretamine—Anaemia—Doxorubicin—thyroid cancer	0.00521	0.00521	CcSEcCtD
Altretamine—Vertigo—Doxorubicin—thyroid cancer	0.00507	0.00507	CcSEcCtD
Altretamine—Leukopenia—Doxorubicin—thyroid cancer	0.00505	0.00505	CcSEcCtD
Altretamine—Convulsion—Doxorubicin—thyroid cancer	0.00489	0.00489	CcSEcCtD
Altretamine—Thrombocytopenia—Epirubicin—thyroid cancer	0.00487	0.00487	CcSEcCtD
Altretamine—Anorexia—Epirubicin—thyroid cancer	0.00474	0.00474	CcSEcCtD
Altretamine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00451	0.00451	CcSEcCtD
Altretamine—Anorexia—Doxorubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Altretamine—Decreased appetite—Epirubicin—thyroid cancer	0.00433	0.00433	CcSEcCtD
Altretamine—Fatigue—Epirubicin—thyroid cancer	0.00429	0.00429	CcSEcCtD
Altretamine—Decreased appetite—Doxorubicin—thyroid cancer	0.004	0.004	CcSEcCtD
Altretamine—Fatigue—Doxorubicin—thyroid cancer	0.00397	0.00397	CcSEcCtD
Altretamine—Asthenia—Epirubicin—thyroid cancer	0.00357	0.00357	CcSEcCtD
Altretamine—Asthenia—Doxorubicin—thyroid cancer	0.0033	0.0033	CcSEcCtD
Altretamine—Dizziness—Epirubicin—thyroid cancer	0.00329	0.00329	CcSEcCtD
Altretamine—Vomiting—Epirubicin—thyroid cancer	0.00316	0.00316	CcSEcCtD
Altretamine—Dizziness—Doxorubicin—thyroid cancer	0.00304	0.00304	CcSEcCtD
Altretamine—Nausea—Epirubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Altretamine—Vomiting—Doxorubicin—thyroid cancer	0.00293	0.00293	CcSEcCtD
Altretamine—Nausea—Doxorubicin—thyroid cancer	0.00273	0.00273	CcSEcCtD
